These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7416274)

  • 1. Plasma and saliva levels of chlorpromazine and subjective response.
    Van Putten T; May PR; Jenden DJ; Cho AK; Yale C
    Am J Psychiatry; 1980 Oct; 137(10):1241-2. PubMed ID: 7416274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorpromazine levels and the outcome of treatment in schizophrenic patients.
    May PR; Van Putten T; Jenden DJ; Yale C; Dixon WJ
    Arch Gen Psychiatry; 1981 Feb; 38(2):202-7. PubMed ID: 7212947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test dose response in schizophrenia: chlorpromazine blood and saliva levels.
    May PR; Van Putten T; Jenden DJ; Cho AK
    Arch Gen Psychiatry; 1978 Sep; 35(9):1091-7. PubMed ID: 686971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective response as a predictor of outcome in pharmacotherapy: the consumer has a point.
    Van Putten T; May PR
    Arch Gen Psychiatry; 1978 Apr; 35(4):477-80. PubMed ID: 727898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promazine. A major plasma metabolite of chlorpromazine in a population of chronic schizophrenics.
    Sgaragli G; Ninci R; Della Corte L; Valoti M; Nardini M; Andreoli V; Moneti G
    Drug Metab Dispos; 1986; 14(2):263-6. PubMed ID: 2870904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does a plasma level of chlorpromazine help?
    Van Putten T; May PR; Jenden DJ
    Psychol Med; 1981 Nov; 11(4):729-34. PubMed ID: 6119719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting outcome of antipsychotic drug treatment from early response.
    May PR; Van Putten T; Yale C
    Am J Psychiatry; 1980 Sep; 137(9):1088-9. PubMed ID: 7425161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of akinesia: plasma chlorpromazine and prolactin levels.
    Van Putten T; May PR; Wilkins JN
    Am J Psychiatry; 1980 Nov; 137(11):1446-8. PubMed ID: 7435684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance.
    Singh MM
    Dis Nerv Syst; 1976 Apr; 37(4):191-6. PubMed ID: 767080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subjective response to antipsychotic drugs: failure to replicate predictions of outcome.
    Ayers T; Liberman RP; Wallace CJ
    J Clin Psychopharmacol; 1984 Apr; 4(2):89-93. PubMed ID: 6707245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorpromazine accumulation and sudden death in a patient with renal insufficiency.
    Dorson PG; Crismon ML
    Drug Intell Clin Pharm; 1988 Oct; 22(10):776-8. PubMed ID: 3229342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immediate effects of chlorpromazine in newly admitted schizophrenic patients.
    Hamill WT; Fontana AF
    Am J Psychiatry; 1975 Oct; 132(10):1023-6. PubMed ID: 1101707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Place of clinical and pharmacokinetic parameters in prognosing the effectiveness of schizophrenic therapy].
    Panteleeva GP; Minsker EI; Tsirkin SIu; Beliaev BS; Lukanina SK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):748-54. PubMed ID: 7415697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Level of free and bound chlorpromazine fractions in the blood and urine during chlorpromazine treatment].
    Nurowska K; Szajbel W; Waszkiewicz E; Welbel L
    Psychiatr Pol; 1970; 4(4):435-42. PubMed ID: 5472581
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic interaction between propranolol and chlorpromazine in schizophrenic patients.
    Peet M; Middlemiss DN; Yates RA
    Lancet; 1980 Nov; 2(8201):978. PubMed ID: 6107617
    [No Abstract]   [Full Text] [Related]  

  • 16. Prediction of response to and actual outcome of chlorpromazine treatment in schizophrenic patients.
    Sakurai Y; Takahashi R; Nakahara T; Ikenaga H
    Arch Gen Psychiatry; 1980 Sep; 37(9):1057-62. PubMed ID: 7416905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of neuroleptics (haloperidol and chlorpromazine) on the pharmacokinetics of valproic acid in schizophrenic patients.
    Ishizaki T; Chiba K; Saito M; Kobayashi K; Iizuka R
    J Clin Psychopharmacol; 1984 Oct; 4(5):254-61. PubMed ID: 6149238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled comparison of SK&F 14336 and chlorpromazine in newly admitted schizophrenics.
    Overall JE; Hollister LE; Prusmack JJ; Shelton J; Pokorny A
    J Clin Pharmacol J New Drugs; 1969; 9(5):328-38. PubMed ID: 4899114
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: A comparative study of thiothixene and chlorpromazine in chronic schizophrenic patients: application of a special psychometric test battery.
    Ruiz-Navarro JF; Vergara L; Deutsch M
    Psychopharmacol Bull; 1976 Jan; 12(1):38-9. PubMed ID: 1108083
    [No Abstract]   [Full Text] [Related]  

  • 20. A possible mechanism for the antischizophrenic action of chlorpromazine: inhibition of the formation of dimethyltryptamine by chlorpromazine metabolites.
    Narasimhachari N; Lin RL
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):341-51. PubMed ID: 4527612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.